Parainfluenza type 3 infection post stem cell transplant: high prevalence but low mortality

Journal of Hospital Infection

Volumn 63, Issue 4, 2006, Pages 452-458

  Dignan, F ^a   Alvares, C ^a   Riley, U ^a   Ethell, M ^a   Cunningham, D ^a   Treleaven, J ^a   Ashley, S ^a   Bendig, J ^b   Morgan, G ^a   Potter, M ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b West Park Hospital   (United Kingdom)

Author keywords

Mortality; Parainfluenza; Prevalence; Ribavirin; Stem cell transplant

Indexed keywords

ALEMTUZUMAB; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUDARABINE; MELPHALAN; RIBAVIRIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ASPERGILLOSIS; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CAUSE OF DEATH; CHRONIC LYMPHATIC LEUKEMIA; COMORBIDITY; CONTROLLED STUDY; DEATH; EPIDEMIC; EPIDEMIOLOGICAL DATA; FEMALE; GRAFT RECIPIENT; HEALTH CARE POLICY; HEALTH SURVEY; HODGKIN DISEASE; HUMAN; INFECTION CONTROL; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MYELOMA; OUTPATIENT; PARAINFLUENZA VIRUS 3; PREVALENCE; RETROSPECTIVE STUDY; RNA VIRUS INFECTION; SEPTICEMIA; SYMPTOM; THORAX RADIOGRAPHY; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CROSS INFECTION; ENGLAND; FEMALE; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; PARAINFLUENZA VIRUS 3, HUMAN; PREVALENCE; RESPIROVIRUS INFECTIONS; RETROSPECTIVE STUDIES; RIBAVIRIN; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33745713958     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2006.03.010     Document Type: Article

References (12)

1. Heilman C.A. Respiratory syncytial and parainfluenza viruses. J Infect Dis 161 (1990) 402-406
2. Ljungman P., Gleaves C.A., and Meyers J.D. Respiratory virus infection in immunocompromised patients. Bone Marrow Transplant 4 (1989) 35-40
3. Nichols W., Corey L., Gooley T., et al. Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood 98 (2001) 573-578
4. Lewis V.A., Champlin R., Englund J., et al. Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients. Clin Infect Dis 23 (1996) 1033-1037
5. Eliziga J., Olavarria E., Apperley J.F., Goldman J.M., and Ward K.N. Parainfluenza virus 3 infection after stem cell transplant: relevance to outcome of rapid diagnosis and ribavirin treatment. Clin Infect Dis 32 (2001) 413-418
6. Chakrabarti S., Collingham K.E., Holder K., Oyalde S., Pillay D., and Millagan D.W. Parainfluenza virus type 3 infections in hematopoietic stem cell transplant recipients: response to ribavirin therapy. Clin Infect Dis 31 (2000) 1516-1518
7. Sparrelid E., Ljungman P., Ekelof-Andstrom E., et al. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections. Bone Marrow Transplant 19 (1997) 905-908
8. Wendt C.H., Welsdorf D.J., Jordan M.C., Balfour Jr. H.H., and Hertz M.I. Parainfluenza virus respiratory infection after bone marrow transplantation. N Engl J Med 326 (1992) 921-926
9. Hall C. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 334 (2001) 1917-1928
10. Cortez K.J., Erdman D.D., Peret T.C.T., et al. Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population. J Infect Dis 184 (2001) 1093-1097
11. Nichols W.G., Erdman D.D., Han A., Zukerman C., Corey L., and Boeckh M. Prolonged outbreak of human parainfluenza virus 3 infection in a stem cell transplant outpatient department: insights from molecular epidemiologic analysis. Biol Blood Marrow Transplant 10 (2004) 58-64
12. Sidwell R.W., Khase G.P., Allen L.B., et al. In vitro and in vivo effect of 1-β-d-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) on types 1 and 3 parainfluenza virus infections. Chemotherapy 21 (1975) 205-220